These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 6424577

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice.
    Wang Y, Sugiyama H, Axelson H, Panda CK, Babonits M, Ma A, Steinberg JM, Alt FW, Klein G, Wiener F.
    Oncogene; 1992 Jun; 7(6):1241-7. PubMed ID: 1375720
    [Abstract] [Full Text] [Related]

  • 3. A new variant 15; 16 translocation in mouse plasmacytoma leads to the juxtaposition of c-myc and immunoglobulin lambda.
    Axelson H, Panda CK, Silva S, Sugiyama H, Wiener F, Klein G, Sumegi J.
    Oncogene; 1991 Dec; 6(12):2263-70. PubMed ID: 1766673
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Ig/myc translocations of the plasmacytoma-prone BALB/c strain occur independently of the genetic and parental origin of the affected chromosomes 6, 12, and 15.
    Silva S, Babonits M, Klein G.
    Genes Chromosomes Cancer; 1996 Nov; 17(3):179-84. PubMed ID: 8946197
    [Abstract] [Full Text] [Related]

  • 7. Previously hidden chromosome aberrations in T(12;15)-positive BALB/c plasmacytomas uncovered by multicolor spectral karyotyping.
    Coleman AE, Schröck E, Weaver Z, du Manoir S, Yang F, Ferguson-Smith MA, Ried T, Janz S.
    Cancer Res; 1997 Oct 15; 57(20):4585-92. PubMed ID: 9377573
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. C-myc-S mu rearrangement in a murine plasmacytoma without visible chromosomal translocations.
    Ohno S, Migita S, Murakami S.
    Oncogene; 1989 Dec 15; 4(12):1513-7. PubMed ID: 2687771
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Insertion of Myc into Igh accelerates peritoneal plasmacytomas in mice.
    Park SS, Shaffer AL, Kim JS, duBois W, Potter M, Staudt LM, Janz S.
    Cancer Res; 2005 Sep 01; 65(17):7644-52. PubMed ID: 16140930
    [Abstract] [Full Text] [Related]

  • 16. Chromosomal translocations deregulating c-myc are associated with normal immune responses.
    Roschke V, Kopantzev E, Dertzbaugh M, Rudikoff S.
    Oncogene; 1997 Jun 26; 14(25):3011-6. PubMed ID: 9223664
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Deletional remodeling of c-myc-deregulating chromosomal translocations.
    Kovalchuk AL, Müller JR, Janz S.
    Oncogene; 1997 Nov 06; 15(19):2369-77. PubMed ID: 9393881
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
    Silva S, Kovalchuk AL, Kim JS, Klein G, Janz S.
    Cancer Res; 2003 Dec 15; 63(24):8656-63. PubMed ID: 14695177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.